Biotechnology
Sales professionals in Biotechnology
These ten professionals have held sales, business development and commercial roles at biotechnology companies. A reader can learn how biotech firms find customers and partners, structure commercial deals, and build the teams that sell their products and services.
Professionals to explore
01—10Beth Thompson - Webb
LinkedInExperience: Chief Commercial Officer · Virica Biotech
Chief Commercial Officer at Virica Biotech since 2023, the only work row listed. Her summary describes more than 30 years of senior leadership experience in the biotechnology and life sciences sectors, and her headline lists growth strategy, business transformations, commercialization and cell and gene therapy.
Bradley Bailey
LinkedInExperience: Executive Vice President & Chief Commercial Officer · Genmab
Executive Vice President & Chief Commercial Officer at Genmab since 2024, with a Senior Vice President & General Manager row there since 2020. Former Ipsen roles include Senior Vice President, Franchise Head, Oncology Global Oncology Leadership Team (2017–2020) and Head of US Oncology Sales & Clinical Nurse Educator Team (2014–2016). His summary describes 25 years in the healthcare industry, launching medicines in oncology and other serious diseases.
Inger Larsen
LinkedInExperience: Senior Director Business Development, Clinical Genomics and Biomarker Services · Crown Bioscience
Former Senior Director Business Development, Clinical Genomics and Biomarker Services at Crown Bioscience (2024–2025), which her highlights describe as a biotechnology research company and full-service CRO. Other listed roles include Senior Director Business Development at Serimmune Inc. (2023–2024) and at ICON plc (2020–2023), Director Sales (North America) at Sibelius Natural Products (2017–2020) and Vice President of Sales at Serametrix (2016).
Kasper Øland
LinkedInExperience: Vice President of Sales · Samsung Biologics
Vice President of Sales at Samsung Biologics since 2026. Former roles include Vice President Business Development EU & APAC at KBI Biopharma (2023–2026), Senior Director, Business Development (2021–2023) and Director, Business Development (2018–2021) at AGC Biologics, and Sales Manager, Nordics at SCIEX (2013–2018). His summary describes commercial leadership in pharma, biopharma and biologics, with a focus on business development and high-performing teams.
Kevin Bezner
LinkedInExperience: Sales Manager · Amgen
Former Sales Manager at Amgen (2003–2008). Also listed are three former Thermo Fisher Scientific roles: Director, Biotechnology and Pharmaceutical Markets - Business Development (2008–2019), Senior Director, US Sales - Laboratory Products Division (2019–2024) and Senior Sales Director, Key Accounts and Product Specialists (2024–2026). His summary describes 25 years of experience as a commercial sales and business development executive driving revenue growth and enterprise partnerships.
Kevin Lannon
LinkedInExperience: Vice President of Business Development · Matica Biotechnology, Inc.
Former Vice President of Business Development (2024), Senior Director of Business Development (2022–2024) and Director of Sales (2021–2022) at Matica Biotechnology, Inc. He has been Senior Director Business Development at Cellares since 2025. His headline lists BD and sales in CDMO and bioprocessing for cell and gene therapy, and describes him as a sales and marketing leader in cell and gene therapy development and manufacturing.
Larry Yu
LinkedInExperience: Senior Director of Sales, North America · ACROBiosystems
Senior Director of Sales, North America at ACROBiosystems since 2026. Former ACROBiosystems roles include Director of Sales, North America (2024–2026), Associate Director Of Sales, North America (2022–2024), Regional Manager, West Coast (2021–2022) and Regional Manager, Southern California (2020–2021). His summary describes leading sales and business development in the biotechnology industry, from conceptual development to large-scale manufacturing of recombinant protein, antibodies and associated products.
Patrick Meyer
LinkedInExperience: Global Head of Business Development & Member of the Executive Committee · Rentschler Biopharma
Global Head of Business Development & Member of the Executive Committee at Rentschler Biopharma since 2025. Former Rentschler Biopharma roles include Global Head of BD Sales & Alliance Management (2024–2025), Senior Director Global Strategic BD (2021–2024), Senior Director Business Development (2021) and Director Business Development (2018–2021). His headline describes driving biotech growth and partnering for innovation.
Pia van der Zee
LinkedInExperience: Chief Commercial Officer (CCO) · Ironic Biotech
Chief Commercial Officer (CCO) at Ironic Biotech since 2026, where she has also held a Board Member row since 2026. Other current rows include Consultant at ZeeWorks and an External Lecturer role at Copenhagen Business School since 2020. Her summary describes more than two decades in international business development, sales and marketing positions in pharma, medtech and biotech, commercializing pharmaceuticals, instruments, consumables and reagents.
Sarah Maxfield
LinkedInExperience: Executive Vice President, BD at Cyprotex & Evotec Development · Evotec
Executive Vice President, BD at Cyprotex & Evotec Development at Evotec since 2025, and former Senior Vice President Business Development at Just - Evotec Biologics (2024–2025). Former FUJIFILM Biotechnologies roles include Global Vice President, Commercial Development (2021–2024) and Vice President Sales, Europe & Asia (2018–2021). Her highlights describe Evotec as a biotechnology research company.
Choose the right perspective
Match the person's company type to your question, since selling research reagents, contract manufacturing services and approved medicines involves different buyers and sales cycles. Check whether their relevant role is current or past and which region it covered.
Questions to take into the conversation
- 01How do biotech companies choose a contract manufacturing or research services partner?
- 02What evidence do scientific buyers need before they adopt a new reagent, platform or service?
- 03How should a growing biotech company build its first commercial or business development team?
Reaching sales professionals in Biotechnology
How can I contact one of these sales professionals in Biotechnology?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 10 companies, including Virica Biotech, Genmab and Crown Bioscience, based on profile data retrieved on October 1, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach sales professionals in Biotechnology?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal